The two companies entered co-marketing and distribution agreement to be implemented worldwide Pressure BioSciences’ high pressure generator technology can improve optical spectroscopy accuracy and data collection with potentially far-reaching impact on drug development The joint technology will be promoted to scientists all over the world and is expected to generate increased sales starting this year … Continue reading “Pressure BioSciences Inc. (PBIO) Agreement with ISS, Inc. Shows Potential to Enhance Drug Discovery and Development”
The tide of cannabis legalization continues to rise Medical cannabis market on pace to hit $56 billion in seven years Company’s proprietary technology improves the bioavailability of cannabinoids With the passage of laws permitting medicinal use of cannabis in at least 32 U.S. jurisdictions and Canada, producers of cannabinoids for medical purposes are racing to … Continue reading “Pressure BioSciences Inc. (PBIO) Just Might Have the Ideal Drug Delivery Technology for Cannabinoids”
Pressure BioSciences (OTCQB: PBIO) this morning said it has entered a two-year, global co-marketing and distribution agreement with ISS, Inc. The companies intend to combine the ISS high pressure optical cell with Pressure BioSciences’ automated high pressure instrument resulting in an exceptional analytical system with the potential to substantially improve biopharmaceutical drug discovery and development. … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Co-Marketing, Distribution Agreement with ISS, Inc.”
Pressure BioSciences Inc. (OTCQB: PBIO) CEO Richard T. Schumacher earlier this week hosted a webinar update and live Q&A session for prospective investors. During the presentation, Schumacher detailed each of PBIO’s three distinct working groups, including its Research Products and Services division, its Biopharmaceutical Manufacturing division and its third group specializing in the development and … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses Recent Corporate Milestones in Webinar Update”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the global life sciences industry, was recently the focus of a publication by Zacks Small Cap Research titled “PBIO: Enters Biopharmaceutical Quality Control Market”. The publication follows the company’s December 20 announcement regarding the release of redesigned software for its … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Entry into Biopharmaceutical Industry Focus of Zacks Small Cap Research Article”
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned software for its Barocycler 2320EXTREME instrument. The result of a year-long collaborative effort between the PBIO team and customers at … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument”
Pressure BioSciences (OTCQB: PBIO) today reported the acquisition of all assets of BaroFold, Inc. The assets acquired include all patents, equipment, and intellectual property relating to BaroFold’s PreEMT™ high-pressure protein refolding technology. A total of eight issued patents and several pending significantly enhances PBIO’s hold of intellectual property in high-pressure technologies. “In addition to the … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Acquires All Assets of BaroFold, Inc.”
Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (OTCQB: PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science”
Pressure Biosciences (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating … Continue reading “Pressure Biosciences, Inc. (PBIO) Starts Presentation at LD Micro Main Event”
Pressure BioSciences (OTCQB: PBIO) recently entered into a strategic collaboration with Phasex Corporation. The company’s goal is to combine its patented Ultra Shear Technology (“UST”) with Phasex’ Supercritical Fluid (“SCF”) processing to cultivate stable, water-soluble nanoemulsions. An article discussing this reads: “Emulsions are mixtures of two or more liquids (e.g., oils and water) that cannot … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Targets Nanoemulsions Market Through Collaboration with Phasex Corp.”
